Transplantation Market Is Projected To Witness Growth Based On Growing Demand For Novel Tissue Transplantation Products Till 2025:Grand View Research,inc.
The global transplantation market is expected to reach USD
51.0 billion by the year 2025, growing at a CAGR of 9.1%, according to a new
report by Grand View Research, Inc. Growing incidence of organ failure has
resulted in massive growth in the transplantation market.
Rising demand for
transplant products such as tissue products, immunosuppressants, and organ
preservation solutions is a major factor anticipated to boost growth of the
market during forecast period. Thus, many biotechnology and medical device
companies have begun to concentrate on the development of advanced transplant
products for management of organ failure.
Technological advancement in
organ transplantation methods is another major factor supporting the market
growth. The development of novel & improved transplant products such as
tissue products and surgical instruments has majorly contributed to the expansion
of the sector. In addition, introduction of advanced tissue products such as
DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix
Collagen Dura Substitute Membrane provides higher benefits during treatment.
In addition, computerized support systems with advanced systems and
software allow easy & effective maintenance of tissues. Thus, availability
of such advanced techniques supports increase in the number of organ transplant
procedures.
U.S. transplantation market,
by product, 2014 - 2025 (USD billion)
Browse full research report on Transplantation
Market Analysis:
Further
key findings from the report suggest:
- Tissue
products segment was the largest revenue-generating amongst others due to
escalating number of tissue and organ transplant procedures
- Tissue
products segment is also expected to grow at highest CAGR owing to
advancement in transplantation products
- Tissue
transplant segment held the largest revenue share in the market, because
of rising number of skin, bones, heart valves, cornea, tendons, nerves,
and veins procedures worldwide
- The
transplant centers segment is projected to grow at the highest CAGR during
the forecast period owing to rising popularity of these centers for
transplant procedures
- The hospitals
segment dominated the market in terms of revenue in 2016 owing to a large
number of transplant procedures performed in hospitals
- North America
was the leading regional sector in 2016 and is projected to maintain its
dominance during the forecast period owing to well-developed healthcare
infrastructure
- Existence of
large number of research laboratories, biotechnology, and medical device
companies in the North America region is the major factor contributing to
its large share
- Some of the
major players include AbbVie, Inc.; Arthrex, Inc.; Zimmer Biomet;
Medtronic; Novartis AG; Stryker; 21st Century Medicine; BioLifeSolutions,
Inc; Teva Pharmaceuticals; and Veloxis Pharmaceuticals.
Comments
Post a Comment